Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination With Fludarabine and Cytarabine, in Pediatric Relapsed or Refractory Acute Leukemia

Alexander Thomas B.; Lacayo Norman J.; Choi John K.; Ribeiro Raul C.; Pui Ching-Hon; Rubnitz Jeffrey E.

首页> 外文期刊>Journal of Clinical Oncology >Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination With Fludarabine and Cytarabine, in Pediatric Relapsed or Refractory Acute Leukemia

【24h】

Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination With Fludarabine and Cytarabine, in Pediatric Relapsed or Refractory Acute Leukemia

机译：I阶段研究Selinexor，核导出选择性抑制剂，与氟赤虫和糖碱相结合，在儿科复发或难治性急性白血病中

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose

机译：目的

著录项

来源
《Journal of Clinical Oncology》 |2016年第34期|共10页
作者
Alexander Thomas B.; Lacayo Norman J.; Choi John K.; Ribeiro Raul C.; Pui Ching-Hon; Rubnitz Jeffrey E.;
展开▼
作者单位

St Jude Childrens Res Hosp 262 Danny Thomas Pl Memphis TN 38105 USA;

Lucile Packard Childrens Hosp Stanford Stanford CA USA;

St Jude Childrens Res Hosp 262 Danny Thomas Pl Memphis TN 38105 USA;

St Jude Childrens Res Hosp 262 Danny Thomas Pl Memphis TN 38105 USA;

St Jude Childrens Res Hosp 262 Danny Thomas Pl Memphis TN 38105 USA;

St Jude Childrens Res Hosp 262 Danny Thomas Pl Memphis TN 38105 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination With Fludarabine and Cytarabine, in Pediatric Relapsed or Refractory Acute Leukemia [J] . Alexander Thomas B., Lacayo Norman J., Choi John K., Journal of Clinical Oncology . 2016,第34期

机译：Selinexor，一种核出口的选择性抑制剂，与氟达拉滨和阿糖胞苷合用，在小儿复发或难治性急性白血病中进行一期研究
2. Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination With Fludarabine and Cytarabine, in Pediatric Relapsed or Refractory Acute Leukemia [J] . Alexander Thomas B., Lacayo Norman J., Choi John K., Journal of Clinical Oncology . 2016,第34期

机译：I阶段研究Selinexor，核导出选择性抑制剂，与氟赤虫和糖碱相结合，在儿科复发或难治性急性白血病中
3. PHASE I STUDY OF SELINEXOR, A SELECTIVE INHIBITOR OF NUCLEAR EXPORT, IN COMBINATION WITH FLUDARABINE AND CYTARABINE IN CHILDREN WITH RELAPSED OR REFRACTORY LEUKEMIA [J] . Alexander Thomas, Ribeiro Raul, Pounds Stanley, Pediatric blood & cancer . 2016,第Suppla1期

机译：一期研究SELINEXOR（一种核出口的选择性抑制剂）与氟达拉滨和阿糖胞苷联用在患有复发性或难治性白血病的儿童中
4. A Phase 1/2 Study of Ixazomib as a Replacement for Bortezomib or Carfilzomib for Multiple Myeloma Patients Recently Relapsed or Refractory to Their Last Combination Regimen Containing Either Bortezomib or Carfilzomib [D] . Forouzan, Eli. 2020

机译：Ixazomib的第1/2期作为替代品髓鞘或胭脂瘤患者的替代品的替代物，最近对含有Bortezomib或Carfilzomib的最后组合方案复发或难治
5. Phase I Study of Selinexor a Selective Inhibitor of Nuclear Export in Combination With Fludarabine and Cytarabine in Pediatric Relapsed or Refractory Acute Leukemia [O] . Thomas B. Alexander, Norman J. Lacayo, John K. Choi, -1

机译：Selinexor一种核出口的选择性抑制剂与氟达拉滨和阿糖胞苷合用在小儿复发或难治性急性白血病中进行一期研究
6. Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination With Fludarabine and Cytarabine, in Pediatric Relapsed or Refractory Acute Leukemia [O] . Thomas B. Alexander, Norman J. Lacayo, John K. Choi, 2016

机译：I阶段研究Selinexor，核导出选择性抑制剂，与氟赤虫和糖碱相结合，在儿科复发或难治性急性白血病中

Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination With Fludarabine and Cytarabine, in Pediatric Relapsed or Refractory Acute Leukemia

摘要

著录项

相似文献

相关主题

期刊订阅